首页> 美国卫生研究院文献>BioMed Research International >Low-Dose-Area-Constrained Helical TomoTherapy-Based Whole Breast Radiotherapy and Dosimetric Comparison with Tangential Field-in-Field IMRT
【2h】

Low-Dose-Area-Constrained Helical TomoTherapy-Based Whole Breast Radiotherapy and Dosimetric Comparison with Tangential Field-in-Field IMRT

机译:低剂量区域约束的基于螺旋层析成像的全乳腺放疗以及与切向场内IMRT的剂量学比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and Purpose. To present a novel helical TomoTherapy-based method for whole breast radiotherapy that has better dosimetry and also has acceptable low-dose regions for lungs, heart, and contralateral breast compared with tangential field-in-field IMRT (FIF-IMRT). Material and Methods. Ten patients with left-side breast cancer were planned with low-dose-area-constrained helical TomoTherapy (LDC-HT) and FIF-IMRT. Dosimetry was compared for all techniques. Results. Coverage of the whole breast was adequate with both techniques. Homogeneity index (HI) and conformity index (CI) were better with LDC-HT. LDC-HT showed dosimetry advantages over FIF-IMRT for ipsilateral lung and heart in not only high-dose levels but also in low-dose levels such as V 10 Gy and V 5 Gy. For contralateral lung, both techniques can provide good protection, although the mean dose of LDC-HT is higher than that of FIF-IMRT. Conclusions. With LDC-HT, we obtained adequate target coverage, better HI and CI of target volume, better sparing of organs at risk, and acceptably low-dose areas compared with FIF-IMRT. LDC-HT could be a feasible method in whole breast radiotherapy. Clinical benefits of LDC-HT need further investigation.
机译:背景和目的。提出一种基于螺旋螺旋层析成像的全乳放射治疗方法,与切向场IMRT(FIF-IMRT)相比,该方法具有更好的剂量测定方法,并且对于肺部,心脏和对侧乳房具有可接受的低剂量区域。材料与方法。计划对十名左侧乳腺癌患者进行低剂量区域限制的螺旋TomoTherapy(LDC-HT)和FIF-IMRT。比较了所有技术的剂量测定法。结果。两种技术都足以覆盖整个乳房。 LDC-HT的同质性指数(HI)和合格指数(CI)更好。对于同侧肺和心脏,LDC-HT在FIF-IMRT方面显示出剂量学优势,不仅在高剂量水平,而且在低剂量水平(例如V 10 Gy和V 5 Gy)方面。对于对侧肺,尽管LDC-HT的平均剂量高于FIF-IMRT的平均剂量,但这两种技术都可以提供良好的保护。结论。与FIF-IMRT相比,使用LDC-HT,我们可以获得足够的靶标覆盖范围,更好的靶标体积HI和CI,更好的保留危险器官以及可接受的低剂量区域。 LDC-HT在全乳放射治疗中可能是一种可行的方法。 LDC-HT的临床益处需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号